PubMed · 1882936
Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.
Abstract
We reviewed the course of 54 patients who had unilateral acute retinal necrosis at initial examination. Thirty-one patients were treated with acyclovir, whereas 23 were not. Of the 31 patients treated with acyclovir, 27 (87.1%) had fellow eyes that remained disease-free throughout a median follow-up of 12 months. Of the 23 patients not treated with acyclovir, seven (30.4%) had fellow eyes that remained disease-free throughout a median follow-up of 11 months. Survival analysis indicated that the fellow eyes of the group of patients treated with acyclovir were more likely to remain disease-free than the fellow eyes of the group not treated with acyclovir (P = .0013). Two years after initial onset, the proportion of fellow eyes that remained disease-free was 75.3% for the group treated with acyclovir and 35.1% for the group not treated with acyclovir. These results suggest that acyclovir treatment reduces the risk of involvement of the fellow eye in patients with acute retinal necrosis.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
D A Palay, P Sternberg, J Davis, H Lewis, G N Holland, W F Mieler, D A Jabs, C Drews. 1991-09-15. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.. https://doi.org/10.1016/s0002-9394(14)76725-x. https://pubmed.health/record/pubmed%3A1882936/decrease-in-the-risk-of-bilateral-acute-retinal-necrosis-by-acyclovir-therapy
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.